STAT Plus: Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

By REBECCA ROBBINS

ALEX HOGAN/STAT

A trade group that represents clinical labs objects to the FDA's crackdown on tests designed to tell patients how genes may interact with specific drugs.

READ MORE